BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9039106)

  • 1. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores.
    Inscho EW; Imig JD; Cook AK
    Hypertension; 1997 Jan; 29(1 Pt 2):222-7. PubMed ID: 9039106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postglomerular vasoconstriction to angiotensin II and norepinephrine depends on intracellular calcium release.
    Imig JD; Cook AK; Inscho EW
    Gen Pharmacol; 2000 Jun; 34(6):409-15. PubMed ID: 11483290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction.
    Inscho EW; Cook AK; Mui V; Imig JD
    Hypertension; 1998 Jan; 31(1 Pt 2):421-8. PubMed ID: 9453339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal arteriolar angiotensin responses during varied adenosine receptor activation.
    Carmines PK; Inscho EW
    Hypertension; 1994 Jan; 23(1 Suppl):I114-9. PubMed ID: 8282342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin.
    Fallet RW; Ikenaga H; Bast JP; Carmines PK
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F545-51. PubMed ID: 15536171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.
    Ichihara A; Imig JD; Inscho EW; Navar LG
    Hypertension; 1998 Jun; 31(6):1255-60. PubMed ID: 9622138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.
    Imig JD; Deichmann PC
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F274-82. PubMed ID: 9277588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.
    Feng MG; Navar LG
    Am J Nephrol; 2004; 24(6):641-8. PubMed ID: 15627720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
    Zhao X; Cook AK; Field M; Edwards B; Zhang S; Zhang Z; Pollock JS; Imig JD; Inscho EW
    Hypertension; 2005 Sep; 46(3):562-8. PubMed ID: 16116048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists.
    Inscho EW; Carmines PK; Navar LG
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F157-63. PubMed ID: 2115739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
    Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
    Schoonmaker GC; Fallet RW; Carmines PK
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F302-9. PubMed ID: 10662734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II.
    Carmines PK; Navar LG
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1015-20. PubMed ID: 2544103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Ca(2+)-activated K(+) channels on rat renal arteriolar responses to depolarizing agonists.
    Fallet RW; Bast JP; Fujiwara K; Ishii N; Sansom SC; Carmines PK
    Am J Physiol Renal Physiol; 2001 Apr; 280(4):F583-91. PubMed ID: 11249849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of tubuloglomerular feedback to renal arteriolar angiotensin II responsiveness.
    Ikenaga H; Fallet RW; Carmines PK
    Kidney Int; 1996 Jan; 49(1):34-9. PubMed ID: 8770946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
    Ohishi K; Carmines PK; Inscho EW; Navar LG
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F900-6. PubMed ID: 1332506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.
    Carmines PK; Fallet RW; Che Q; Fujiwara K
    Hypertension; 2001 Feb; 37(2 Pt 2):569-73. PubMed ID: 11230336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary myo-inositol restores diabetic renal arteriolar reactivity to angiotensin II but not to norepinephrine.
    Inman SR; Porter JP; Fleming JT
    Microcirculation; 1996 Jun; 3(2):191-8. PubMed ID: 8839441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
    Liu ZZ; Mathia S; Pahlitzsch T; Wennysia IC; Persson PB; Lai EY; Högner A; Xu MZ; Schubert R; Rosenberger C; Patzak A
    Am J Physiol Renal Physiol; 2017 May; 312(5):F908-F916. PubMed ID: 28052871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.